• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英格兰微创表面活性剂给药调查:采用缓慢且实践方式各异

Survey of less Invasive Surfactant Administration in England, slow adoption and variable practice.

作者信息

Bhayat Sadaf, Kaur Avineet, Premadeva Irnthu, Reynolds Peter, Gowda Harsha

机构信息

Neonatal Unit, University College London Hospitals NHS Foundation Trust, London, UK.

Neonatal Unit, Luton and Dunstable University Hospital NHS Foundation Trust, Luton, UK.

出版信息

Acta Paediatr. 2020 Mar;109(3):505-510. doi: 10.1111/apa.14995. Epub 2019 Sep 16.

DOI:10.1111/apa.14995
PMID:31471992
Abstract

AIM

National survey to evaluate the uptake of Less Invasive Surfactant Administration (LISA) in neonatal units across England.

METHODS

A web-based survey was sent out by email to all 150 neonatal units in England. It consisted of questions regarding indications for LISA, the practicalities of the procedure and reasons for not using this technique.

RESULTS

The response rate was 96% (144/150 units). Only 11% of units are using LISA, but majority (78%) would consider implementing LISA on their unit. 56% would also consider LISA on delivery suite. Challenges identified are having a guideline and staff training. 61% of units have set the target population ≥27 weeks. On sub-analysis, for tertiary units, the trend for LISA is ≥26 weeks. The median FiO threshold for LISA is 0.3 (IQR 0.3-0.4) in less than 28 weeks gestational age (GA), and 0.4 in higher gestations. The most common suggestion for premedication is fentanyl (32%).

CONCLUSION

The uptake of LISA in England is low comparing to the rest of Europe. Even though many units are considering implementing LISA, there is lack of training and national guidelines. There is urgent need for standardisation of practice and clear indications for LISA.

摘要

目的

开展全国性调查,以评估英格兰各新生儿病房对微创表面活性剂给药法(LISA)的采用情况。

方法

通过电子邮件向英格兰所有150个新生儿病房发送了一项基于网络的调查问卷。问卷包含有关LISA适应症、该操作的实际情况以及不使用该技术的原因等问题。

结果

回复率为96%(144/150个病房)。只有11%的病房正在使用LISA,但大多数病房(78%)会考虑在其病房实施LISA。56%的病房还会考虑在产房使用LISA。已确定的挑战包括制定指南和进行员工培训。61%的病房将目标人群设定为≥27周。在亚组分析中,对于三级病房,LISA的趋势是≥26周。在胎龄小于28周(GA)时,LISA的中位吸氧浓度阈值为0.3(四分位间距0.3 - 0.4),在胎龄较大时为0.4。最常见的预处理建议是使用芬太尼(32%)。

结论

与欧洲其他地区相比,LISA在英格兰的采用率较低。尽管许多病房正在考虑实施LISA,但缺乏培训和国家指南。迫切需要规范操作并明确LISA的适应症。

相似文献

1
Survey of less Invasive Surfactant Administration in England, slow adoption and variable practice.英格兰微创表面活性剂给药调查:采用缓慢且实践方式各异
Acta Paediatr. 2020 Mar;109(3):505-510. doi: 10.1111/apa.14995. Epub 2019 Sep 16.
2
European perspective on less invasive surfactant administration-a survey.欧洲对于微创表面活性剂给药的观点——一项调查
Eur J Pediatr. 2017 Feb;176(2):147-154. doi: 10.1007/s00431-016-2812-9. Epub 2016 Dec 9.
3
A national survey on use of less invasive surfactant administration in Turkey.一项关于在土耳其使用较少有创性肺表面活性剂治疗的全国性调查。
Turk J Pediatr. 2020;62(5):787-794. doi: 10.24953/turkjped.2020.05.010.
4
Premedication with Fentanyl for Less Invasive Surfactant Application (LISA): A Randomized Controlled Trial.氟芬太尼预处理用于微创表面活性剂应用(LISA):一项随机对照试验。
J Trop Pediatr. 2022 Feb 3;68(2). doi: 10.1093/tropej/fmac019.
5
Respiratory monitoring during less invasive surfactant administration in the delivery suite.产房内经鼻持续气道正压通气时的呼吸监测。
Early Hum Dev. 2021 Mar;154:105311. doi: 10.1016/j.earlhumdev.2021.105311. Epub 2021 Jan 22.
6
Implementation of less-invasive surfactant administration in a Canadian neonatal intensive care unit.加拿大新生儿重症监护病房中实施微创表面活性剂给药。
Arch Pediatr. 2022 Aug;29(6):444-447. doi: 10.1016/j.arcped.2022.05.010. Epub 2022 Jun 3.
7
A Survey of Less Invasive Surfactant Administration Usage in India.印度微创表面活性剂给药使用情况调查。
Indian J Pediatr. 2023 Feb;90(2):181-183. doi: 10.1007/s12098-022-04390-y. Epub 2022 Nov 15.
8
Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.经鼻给予肺表面活性物质与气管内给予肺表面活性物质后行小潮气量通气治疗中国呼吸窘迫综合征早产儿的随机对照试验研究方案
Trials. 2020 Jun 11;21(1):516. doi: 10.1186/s13063-020-04390-3.
9
Analgosedation for less-invasive surfactant administration: Variations in practice.经鼻给予表面活性物质时的镇静:实践中的差异。
Pediatr Pulmonol. 2024 Mar;59(3):750-757. doi: 10.1002/ppul.26826. Epub 2023 Dec 26.
10
Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.在患有呼吸窘迫综合征的早产儿中进行的微创表面活性剂给药
J Coll Physicians Surg Pak. 2019 Mar;29(3):226-330. doi: 10.29271/jcpsp.2019.03.226.

引用本文的文献

1
Dexmedetomidine for Less Invasive Surfactant Administration: Another Promising Medicine in an Ever-Growing Toolbox?右美托咪定用于微创表面活性剂给药:不断扩充的工具库中的又一种有前景的药物?
Paediatr Drugs. 2025 Mar;27(2):257-260. doi: 10.1007/s40272-024-00678-y. Epub 2025 Jan 8.
2
Changes in practice of less-invasive surfactant administration (LISA) in United Kingdom neonatal units.英国新生儿病房微创表面活性剂给药(LISA)实践的变化
Acta Paediatr. 2025 Feb;114(2):393-397. doi: 10.1111/apa.17446. Epub 2024 Oct 8.
3
Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants.
导管厚度对极早产儿微创表面活性剂给药期间呼吸生理的影响。
Front Pediatr. 2024 Sep 17;12:1352784. doi: 10.3389/fped.2024.1352784. eCollection 2024.
4
Creation of a rating scale to teach Less Invasive Surfactant Administration (LISA) in simulation.创建一个评分量表,用于在模拟教学中教授 Less Invasive Surfactant Administration(LISA)。
BMC Med Educ. 2024 Feb 14;24(1):146. doi: 10.1186/s12909-024-05118-6.
5
Comparison of Outcomes of Less Invasive Surfactant Administration in Prematurely Born Infants in the Delivery Suite and the Neonatal Unit.比较在产房和新生儿病房中对早产儿进行微创表面活性剂给药的效果。
Am J Perinatol. 2024 May;41(S 01):e2674-e2678. doi: 10.1055/a-2142-9434. Epub 2023 Jul 27.
6
Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study.经鼻持续气道正压通气与鼻塞持续气道正压通气治疗新生儿呼吸窘迫综合征的系统评价和 Meta 分析
Pediatr Res. 2023 Sep;94(3):1216-1224. doi: 10.1038/s41390-023-02621-2. Epub 2023 May 4.
7
Premedication before laryngoscopy in neonates: Evidence-based statement from the French society of neonatology (SFN).新生儿喉镜检查前的预处理:法国新生儿学会(SFN)的循证声明
Front Pediatr. 2023 Jan 4;10:1075184. doi: 10.3389/fped.2022.1075184. eCollection 2022.
8
Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.经鼻持续气道正压通气与肺表面活性物质联合鼻塞式气道正压通气治疗早产儿呼吸窘迫综合征的临床疗效比较 目的:探讨经鼻持续气道正压通气(NCPAP)与肺表面活性物质(PS)联合鼻塞式气道正压通气(CPAP)治疗早产儿呼吸窘迫综合征(NRDS)的临床疗效。方法:选择 2019 年 1 月至 2020 年 12 月在我院接受治疗的 86 例 NRDS 早产儿作为研究对象,按照随机数字表法分为观察组和对照组,每组 43 例。观察组给予 NCPAP 联合 PS 治疗,对照组给予 CPAP 联合 PS 治疗。比较两组患儿的临床疗效、血气指标、机械通气时间、住院时间及不良反应发生情况。结果:观察组患儿的总有效率为 95.35%,明显高于对照组的 76.74%(P<0.05)。治疗后,观察组患儿的 PaO2、SaO2 水平明显高于对照组,PaCO2 水平明显低于对照组(P<0.05)。观察组患儿的机械通气时间和住院时间明显短于对照组(P<0.05)。观察组患儿的不良反应总发生率为 4.65%,明显低于对照组的 18.60%(P<0.05)。结论:NCPAP 联合 PS 治疗 NRDS 早产儿的临床疗效优于 CPAP 联合 PS 治疗,能有效改善血气指标,缩短机械通气时间和住院时间,降低不良反应发生率。
BMC Pulm Med. 2022 Dec 5;22(1):462. doi: 10.1186/s12890-022-02270-x.
9
Teaching fiberoptic-assisted tracheoscopy in very low birth weight infants: A randomized controlled simulator study.极低出生体重儿的纤维支气管镜辅助气管镜检查教学:一项随机对照模拟研究。
Front Pediatr. 2022 Sep 8;10:956920. doi: 10.3389/fped.2022.956920. eCollection 2022.
10
A survey of minimally invasive surfactant therapy in Canada.加拿大微创表面活性剂疗法调查。
Can J Respir Ther. 2022 Jul 28;58:122-126. doi: 10.29390/cjrt-2022-011. eCollection 2022.